Drug Shortage Report for JAMP-CETIRIZINE
Report ID | 149821 |
Drug Identification Number | 02466171 |
Brand name | JAMP-CETIRIZINE |
Common or Proper name | Cetirizine hydrochloride tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | MARKETED |
Active Ingredient(s) | CETIRIZINE HYDROCHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | TABLET TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | R06AE |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2021-11-04 |
Estimated end date | 2022-06-17 |
Actual end date | 2022-06-13 |
Shortage status | Resolved |
Updated date | 2022-07-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-07-19 | English | Compare |
v10 | 2022-06-13 | French | Compare |
v9 | 2022-06-13 | English | Compare |
v8 | 2022-05-17 | French | Compare |
v7 | 2022-05-17 | English | Compare |
v6 | 2022-04-06 | French | Compare |
v5 | 2022-04-06 | English | Compare |
v4 | 2022-02-14 | French | Compare |
v3 | 2022-02-14 | English | Compare |
v2 | 2021-11-24 | French | Compare |
v1 | 2021-11-24 | English | Compare |
Showing 1 to 11 of 11